pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
acetaminophen ER
Acetaminophen (acetaminophen)
Dysmenorrhea
Granules USA Inc
1,021 catalysts
Marketed
pembrolizumab
Keytruda (pembrolizumab)
Merkel Cell Carcinoma
Programmed cell death protein 1
$MRKMerck & Co., Inc.
125 catalysts
Marketed
nivolumab
Opdivo (nivolumab)
Colorectal Cancer
Programmed cell death protein 1
← prev
page 1 of 231
next →
131
Pain89
Neurology1
Bristol-Myers Squibb Co
86 catalysts
Marketed
tocilizumab
Actemra (tocilizumab)
Coronavirus Disease 2019 (COVID-19)
Genentech Inc
61 catalysts
Marketed
PROPOFOL
PROPOFOL (PROPOFOL)
Pain
Bika Biotechnology Guanzhou Co Ltd
48 catalysts
Marketed
atezolizumab
Tecentriq (atezolizumab)
Muscle Invasive Bladder Cancer (MIBC)
Programmed cell death 1 ligand 1
F. Hoffmann-La Roche Ltd
41 catalysts
Marketed
doxycycline ER
Doxycycline Prasco (doxycycline)
Rosacea
Prasco LLC
39 catalysts
Marketed
PHYTONADIONE
PHYTONADIONE (PHYTONADIONE)
$SIGYSigyn Therapeutics, Inc.
37 catalysts
Marketed
MEDROL
MEDROL (METHYLPREDNISOLONE)
Glucocorticoid receptor
$PFEPFIZER INC
34 catalysts
Marketed
dupilumab
Dupixent (dupilumab)
Chronic Urticaria
Interleukin-4 receptor subunit alpha
$REGNREGENERON PHARMACEUTICALS, INC.
33 catalysts
Marketed
blinatumomab
Blincyto (blinatumomab)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
B-lymphocyte antigen CD19T cell surface glycoprotein CD3
$AMGNAMGEN INC
25 catalysts
Marketed
cabozantinib s-malate
Cometriq (cabozantinib s-malate)
Endometrial Cancer
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
$EXELEXELIXIS, INC.
25 catalysts
Marketed
venetoclax
Venclexta (venetoclax)
Mantle Cell Lymphoma
Apoptosis regulator Bcl-2
$ABBVAbbVie Inc.
22 catalysts
Marketed
DAPAGLIFLOZIN
DAPAGLIFLOZIN (DAPAGLIFLOZIN)
Type 2 Diabetes
Lupin Ltd
21 catalysts
Marketed
ISOTRETINOIN
ISOTRETINOIN (ISOTRETINOIN)
Severe Recalcitrant Nodular Acne
Amneal Pharmaceuticals of New York LLC
21 catalysts
Marketed
dexmedetomidine
Igalmi (dexmedetomidine)
Bipolar Disorder (Manic Depression)
Adrenergic receptor alpha-2
$BTAIBioXcel Therapeutics, Inc.
18 catalysts
Marketed
cemiplimab
Libtayo (cemiplimab-rwlc)
Melanoma
Programmed cell death protein 1
$REGNREGENERON PHARMACEUTICALS, INC.
17 catalysts
Marketed
amoxicillin
Larotid (amoxicillin)
Gonorrhea
NeoPharma Inc
15 catalysts
Marketed
VALPROATE SODIUM
VALPROATE SODIUM (VALPROATE SODIUM)
Absence Seizure
Sagent Pharmaceuticals Inc
14 catalysts
Marketed
bupivacaine
Exparel (bupivacaine)
Post-Operative Pain
Sodium channel protein type 4 subunit alpha
Allay Therapeutics Inc
14 catalysts
Marketed
CALQUENCE
CALQUENCE (ACALABRUTINIB)
Tyrosine-protein kinase BTK
$AZNASTRAZENECA PLC
13 catalysts
Marketed
asciminib hydrochloride
Scemblix (asciminib hydrochloride)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$NVSNOVARTIS AG
13 catalysts
ayurvedic medicine
Rajiv Gandhi Government Post-Graduate Ayurvedic College
11 catalysts
Marketed
dexamethasone
Hemady (dexamethasone [INN])
Multiple Myeloma (Kahler Disease)
Fera Pharmaceuticals LLC
10 catalysts
Marketed
Maxtrex
Methotrexate Sodium (methotrexate)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
$PFEPFIZER INC
8 catalysts
Marketed
stiripentol
Diacomit (stiripentol)
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Biocodex
8 catalysts
Marketed
LIDOCAINE
LIDOCAINE (LIDOCAINE)
Postherpetic Neuralgia
Sodium channel alpha subunit
MEDRx Co Ltd
5 catalysts
Phase 3
bevacizumab
Avastin (bevacizumab)
Melanoma
Vascular endothelial growth factor A, long form
F. Hoffmann-La Roche Ltd
5 catalysts
Marketed
capivasertib
Truqap (capivasertib)
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Serine/threonine-protein kinase AKT
$AZNASTRAZENECA PLC
5 catalysts
Phase 3
ranibizumab biosimilar
Cimerli (RANIBIZUMAB-EQRN)
Wet (Neovascular / Exudative) Macular Degeneration
Vascular endothelial growth factor A, long form
Lupin Ltd
5 catalysts